Bladder Perforation Following Transurethral Resection of Bladder Tumor With Immediate Intravesical Instillation of Epirubicin Authors: Junya Abe, Atsuro Sawada, Chie Onizuka, Takahiro Akioka, Naoko Nakai, Shimpei Kojima, Hiroki Sakamoto, Tomoya Horinouchi, Toshiyuki Kamoto Published: 2026 ABSTRACT ABSTRACTIntroductionImmediate postoperative intravesical chemotherapy following transurethral resection of bladder tumor (TURBT) is the standard procedure aimed at reducing recurrence.Case PresentationAn 84‐year‐old man was diagnosed with an incidental 13‐mm intravesical tumor during screening for biochemical recurrence following radiation therapy for prostate cancer. Accordingly, he underwent TURBT, followed by immediate postoperative intravesical chemotherapy with epirubicin. On postoperative day 2, he developed abdominal pain. Computed tomography demonstrated bladder perforation accompanied by retroperitoneal free air. He was diagnosed with extraperitoneal bladder perforation and thus managed with urethral catheterization; however, conservative treatment failed. Consequently, surgical repair with debridement was performed. Pale whitish granulation tissue was observed within the perivesical fat, suggesting epirubicin extravasation. Subsequently, cystography performed 28 days after bladder repair showed no contrast extravasation.ConclusionsSurgical treatment should be considered as a potential treatment option for patients with suspected chemotherapy extravasation in whom conservative management is unsuccessful.Keywords: epirubicin, intravesical chemotherapy, transurethral resection of bladder tumor Case Presentation An 84‐year‐old man who had undergone external beam radiation therapy for prostate cancer (cT3aN0M0) 14 years earlier developed biochemical recurrence. Computed tomography (CT) revealed an incidental 13‐mm intravesical tumor on the bladder wall without evidence of metastasis. Accordingly, androgen deprivation therapy was initiated, and transurethral resection of the bladder tumor (TURBT) was performed. A pedunculated papillary tumor was identified at the bladder dome. The tumor was resected, and the deep layer was biopsied and fulgurated. No intraoperative bladder perforation was recognized. Immediate postoperative intravesical chemotherapy with 30 mg of epirubicin in 40 mL of normal saline was administered and retained in the bladder for 1 h. He developed a transient fever, which improved spontaneously. On postoperative day 1, laboratory testing showed an elevated white blood cell count of 28 600/μL without accompanying symptoms or fever. Given the transient fever and marked leukocytosis, he was diagnosed with a postoperative febrile urinary tract infection and was treated with ceftriaxone. On postoperative day 2, he developed abdominal pain with lower abdominal tenderness. CT revealed bladder perforation with retroperitoneal free air without fluid collection (Figure 1A). Accordingly, he was diagnosed with an extraperitoneal bladder perforation. Urethral catheterization was continued with expectation of spontaneous healing. Urine and blood cultures obtained during the febrile episode were negative. However, cystography performed on postoperative days 7 and 13 showed persistent contrast extravasation (Figure 1B). Extravesical leakage of epirubicin was suspected, which may have contributed to tissue necrosis and delayed healing, given the limited extent of resection and lack of improvement with conservative management. (A) Plain CT reveals free air in the retroperitoneal perivesical space. (B) Cystography demonstrates persistent contrast extravasation on postoperative day 13. Therefore, conservative management was discontinued, and surgical repair with debridement was performed on postoperative day 20. Indurated perivesical fat and pale whitish granulation tissue were observed, suggesting tissue damage caused by epirubicin extravasation (Figure 2). The granulation tissue was excised, and a 1‐cm perforation of the bladder wall was identified. The bladder defect was closed using a two‐layer repair technique. The drain was positioned anterior to the bladder and subsequently removed on postoperative day 3. Cystography performed 28 days after repair showed no contrast extravasation, and thus the urethral catheter was subsequently removed (Figure 3). Pale granulation tissue was observed within the perivesical fat. Cystography demonstrates no contrast extravasation postoperatively. Discussion TURBT is the primary diagnostic and therapeutic modality for bladder cancer and provides pathological staging information. Bladder perforation is a well‐recognized complication associated with TURBT, with a reported incidence of 1.6%–5.5% [1]. Immediate intravesical chemotherapy administered within 24 h post‐TURBT has been demonstrated to reduce the risk of tumor recurrence, particularly in patients with an initial presentation or infrequent recurrence of low‐grade, small‐sized tumors [2]. In one study evaluating immediate intravesical mitomycin C, suspected extravasation was reported in 0.57% of patients; however, none of them required surgical intervention [3]. Prolonged urethral catheterization for 3–7 days is the common management strategy for extraperitoneal bladder perforation after TURBT [4]. In the present case, a simple perforation was initially considered, and catheterization was continued in expectation of spontaneous healing. However, contrast extravasation persisted for more than 13 days. Therefore, extravesical leakage of epirubicin may have contributed to delayed healing. This is biologically plausible because epirubicin is classified as a vesicant and is among the most tissue‐destructive antineoplastic agents. Considering that chemotherapy leakage cannot be directly confirmed, establishing a definitive diagnosis is often challenging. Although bladder perforation following TURBT is well documented, only about 30 cases of chemotherapy extravasation have been reported in the literature to the best of our knowledge. Occult bladder wall injury during TURBT with subsequent chemical tissue damage may be one possible mechanism. Among these, only one case of perforation was identified intraoperatively [5]. Symptom onset occurred at a mean of 9.4 days and a median of 4 days postoperatively (Table 1) [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. In several cases, diagnosis was challenging and thus delayed. Therefore, radiological evaluation should be considered in cases where the clinical course deviates from the expected postoperative recovery. TABLE 1Summarizes the time course and clinical findings leading to diagnosis in previously reported cases with available data.YearAuthorAgeSexT stageRegimenTiming of instillationCatheter removal (POD)Symptom onset (POD)Day of diagnosis (POD)Diagnostic modality2003Nieuwenhuijzen JA [6]53MaleNRMMCEarly postoperativelyNR1414CT2004J.R. Oddens [7]88MaleNREpirubicinImmediate144CT2004Marco Racioppi [8]73FemalepT1MMCWithin 48 hNot removed33CT2008Dnagle [9]72FemaleNRMMCPerioperativelyNR4270CT2009S. I. Tyritzis [10]82MalepT1EpirubicinAt 24 and 48 hNR22CT2009S. I. Tyritzis [10]73MaleNREpirubicinAt 24 and 48 h31220CT2009Adem Fazlıoglu [11]76MalepTaMMC2 h postoperativelyNot removed03CT2010Darwin Lim [12]79MalepTaMMCImmediate011Cystography2012Marta Penna [13]77MalepTaMMCPostoperatively222CT2019Humam Hatem [14]74FemalepTaMMCEarly postoperatively2810CT2021Adel Alrabadi [15]63MalepTaDOXAfter 6 h22121MRI2025Nai‐Wen Chang [16]70sMalepTaMMCImmediate244CT cystographyAbbreviations: CT, computed tomography; DOX, doxorubicin; MMC, mitomycin C; NR, not reported; POD, postoperative day. Summarizes the time course and clinical findings leading to diagnosis in previously reported cases with available data. Abbreviations: CT, computed tomography; DOX, doxorubicin; MMC, mitomycin C; NR, not reported; POD, postoperative day. Among 31 reported cases describing management strategies, 12 were treated conservatively with prolonged urethral catheterization, and three underwent drainage procedures. Elmamoun et al. reported catheterization durations ranging from 2 to 52 weeks [17], and other reports were within a similar range. The wide variation likely reflects differences in the severity and extent of tissue injury. In addition, some conservatively managed cases may have represented simple bladder perforation rather than chemotherapy extravasation–associated tissue damage. Given that prolonged catheterization for several months may significantly burden patients, surgical repair should be considered when clinically feasible. Among the 31 cases, 16 underwent surgical intervention. Of these, 14 were initially managed with prolonged catheterization; however, conservative management ultimately failed, necessitating surgery. Two cases underwent immediate surgery without conservative management [10, 18]. The most common surgical approach was debridement with bladder repair, similar to that performed in the present case. Other reported procedures included fecal diversion [7], cystectomy with urinary diversion [5, 9], urinary diversion alone, and partial cystectomy with ureteroureterostomy and augmentation cystoplasty [17]. Clinicians should be aware that management strategies must be tailored according to the location and extent of tissue injury and involvement of adjacent organs. Debridement is particularly important in cases with infected necrotic tissue. Fatal outcomes have been reported when debridement was not feasible due to necrotic adherence to adjacent bowel and in cases managed with percutaneous drainage alone [7, 16]. In addition, two cases developed pancytopenia, possibly due to systemic absorption of epirubicin [8, 16]. These severe complications underscore the importance of early recognition and timely surgical intervention. Conclusion Clinicians should consider chemotherapy extravasation when postoperative symptoms are prolonged or atypical, even in the absence of recognized intraoperative bladder perforation. Surgical treatment is a viable option for patients with chemotherapy extravasation. Surgical treatment should be considered when conservative management fails, and the optimal surgical approach should be selected according to the location and extent of tissue injury. Consent Verbal informed consent for publication of this case report and accompanying images was obtained from the patient. Conflicts of Interest The authors declare no conflicts of interest.